PRESS RELEASE – New Jersey/New York, March 28, 2023 – Jonathan Levitt, a renowned trial attorney in the healthcare and life sciences industries and the co-founding partner of Frier Levitt, has been invited to testify before the U.S. Senate... Read More
On Thursday, January 12, 2023, Governor Ron DeSantis announced a legislative proposal to regulate “unchecked” Pharmacy Benefit Managers (“PBMs”) operating in Florida. According to Governor DeSantis, the proposed legislation is designed to... Read More
As Frier Levitt has highlighted in recent articles, independent pharmacies are encouraged to use all available tools to combat unjustified PBM audit findings. Pharmacies should exhaust their efforts, even in instances where the amount of monies at... Read More
On Thursday, February 17, 2022, the Federal Trade Commission (FTC) deadlocked 2-2 on a proposal to issue Orders to large pharmacy benefits managers to study the competitive impact of contractual provisions, reimbursement adjustments, and other... Read More
Inventory maintenance, a routine undertaking in most businesses, is among the most crucial tasks performed by pharmacists and may have profound repercussions if not handled accurately. In particular, inventory shortages are common discrepancies... Read More
On October 26, 2020, the Food and Drug Administration (FDA) issued its long awaited final MOU which describes the conditions under which certain compounded drugs by a pharmacist in a state-licensed pharmacy, or by a licensed physician, are exempt... Read More
Frier Levitt Partner, Todd Mizeski, Esq. has an article featured in the current issue of Drug Topics discussing the Rutledge v. Pharmaceutical Care Management Association case that recently went before the Supreme Court (SCOTUS). The SCOTUS’s... Read More
With the November elections looming, the policy environment for pharmacy issues hangs in the balance. Who will control the halls of Congress as well as the state legislature will be key in determining the pace of pharmacy... Read More
